ArticleAnnals of medicine and surgery (2012)2025

Targeting transthyretin (TTR) stability for amyloid cardiomyopathy: a landmark shift in heart failure therapy.

Muddassir Khalid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.